Skip to content

Clinical trials

Phase 2/3 Polymyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polymyositis Phase: Phase 2/3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20111
20141
20151
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Northwell Health1
Royal Brompton & Harefield NHS Foundation Trust1
Tokyo Medical and Dental University1
University of Michigan1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis8
Polymyositis8
Myositis5
Lung Diseases, Interstitial3
Connective Tissue Diseases2
Mixed Connective Tissue Disease2
Myositis, Inclusion Body2
Scleroderma, Diffuse2
Arthritis, Rheumatoid1
Myalgia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.